An observational study in Premature Infant, Hemostasis, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 0 Months to 18 Months. Per ClinicalTrials.gov, last updated 2026-01-16.
Sponsored by University Hospital, Strasbourg, France · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 205 studies in Premature Birth with a site in France — 40 open to participants now, 46 under way, 2 of them phase 3. Premature Birth · France.
Among the 205 studies in Premature Birth with a site in France, this one is the 8th largest by planned enrollment of the 99 observational ones that give a count, is one of 11 that started in 2025, is one of 99 observational ones, reaches primary completion later than 44 of the 45 other live ones, and was the 197th registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →40 of the 205 studies in Premature Birth with a site in France are open now. Recruiting first, the newest first:
Institut National de la Santé Et de la Recherche Médicale, France · Sites in France
Ages up to 5 mo · Healthy volunteers
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 6 yrs–78 mo
Bioprojet · Sites in France
Ages 18–50 · Men only
Hospices Civils de Lyon · Sites in France
Ages up to 32 wk
Hospices Civils de Lyon · Sites in France
Ages up to 5 mo
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: 0 Months to 18 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
205 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 6 · Phase 3 12 · Phase 4 10
First in 1997; this study’s year is marked. 11 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,000 is above the median of 120 across 809 observational studies indexed under Premature Birth.
Median enrollment 98 across the 104 interventional studies, 130 across the 99 observational. Of the 139 that completed or were terminated, 2 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 205 have an industry lead sponsor. The 10 most frequent:
University Hospital, Strasbourg, France is the lead sponsor of 1,000 studies on the registry; 359 are open to participants now.
University Hospital, Strasbourg, France has 8 studies filed under Premature Birth — fewer than ten, so there is no comparison to draw.
16 of the studies in Premature Birth with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03976063Phase 3Assistance Publique - Hôpitaux de ParisTocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation | 2026-11 |
| NCT04372953Murdoch Childrens Research InstitutePositive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial). | 2026-11-30 |
| NCT06064825Institut National de la Santé Et de la Recherche Médicale, FranceLong Term Follow-up of the TREOCAPA Study (TREOCAPA-LT) | 2026-12 |
| NCT07047404BioprojetProof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation | 2026-12 |
| NCT07169110University Hospital, ToulouseStudy of the Interprofessional Reproducibility of a Clinical Observation Scale for the Development of Very Premature Infants | 2026-12-30 |
Add all 16 to your calendar (.ics) → With an account.
Among the 205 studies in Premature Birth with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.
Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Normal hemostasis values in premature infants
Normal hemostasis values in premature infants will be determined according to the gestational age at birth
Time frame: Up to 6 years
Started Nov 2025 (actual). Primary completion is estimated for Nov 2031, 72 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →